Allergan (Acquired 2015) Overview

  • Year Founded
  • 1948

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16,000

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 18

Allergan (Acquired 2015) General Information

Description

Developer of pharmaceuticals products based in Irvine, California.. The company is focused on discovering, developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter consumer products. Its products include: BOTOX® (onabotulinumtoxinA), RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%, LUMIGAN® (bimatoprost ophthalmic solution) 0.01%, BOTOX® Cosmetic (onabotulinumtoxinA) and the JUVÉDERM® family of dermal fillers.

Contact Information

Formerly Known As
Botox maker
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2525 Dupont Drive
  • Irvine, CA 92612
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Other Devices and Supplies
Acquirer
Vertical(s)
Corporate Office
  • 2525 Dupont Drive
  • Irvine, CA 92612
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allergan (Acquired 2015) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Allergan (Acquired 2015)‘s full profile, request access.

Request a free trial

Allergan (Acquired 2015) Patents

Allergan (Acquired 2015) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022204209-A1 Aspiration and injection device Pending 16-Jun-2022
US-20230011907-A1 Methods and apparatus for delivery of ocular implants Pending 08-Jul-2021
AU-2022308357-A1 Methods and apparatus for delivery of ocular implants Pending 08-Jul-2021
CA-3221697-A1 Methods and apparatus for delivery of ocular implants Pending 08-Jul-2021
EP-4366674-A1 Methods and apparatus for delivery of ocular implants Pending 08-Jul-2021 A61F9/0017
To view Allergan (Acquired 2015)’s complete patent history, request access »

Allergan (Acquired 2015) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allergan (Acquired 2015) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Allergan (Acquired 2015)‘s full profile, request access.

Request a free trial

Allergan (Acquired 2015) Investments & Acquisitions (18)

Allergan (Acquired 2015)’s most recent deal was a Corporate Asset Purchase with Taris Biomedical (LiRIS) for . The deal was made on 19-Aug-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Taris Biomedical (LiRIS) 19-Aug-2014 Corporate Asset Purchase Buildings and Property
Aline Aesthetics (Aline Hyaluronic Acid Thread Technology) 17-Apr-2014 Corporate Asset Purchase Buildings and Property
Exemplar Pharma 12-Apr-2013 Merger/Acquisition Drug Delivery
Map Pharmaceuticals 23-Jan-2013 Merger/Acquisition Pharmaceuticals
SkinMedica 19-Dec-2012 Merger/Acquisition Personal Products
You’re viewing 5 of 18 investments and acquisitions. Get the full list »

Allergan (Acquired 2015) Exits (3)

Allergan (Acquired 2015)’s most recent exit was on 22-Jul-2011 from EMKinetics. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
EMKinetics 22-Jul-2011 Completed
  • 7 buyers
Ista Pharmaceuticals 01-Mar-2000 Completed
Abbott Medical Optics 01-Jan-1986 Merger/Acquisition Completed
To view Allergan (Acquired 2015)’s complete exits history, request access »

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Legacy Allergan Pension Plan North Chicago, IL 1989

Allergan (Acquired 2015) FAQs

  • When was Allergan (Acquired 2015) founded?

    Allergan (Acquired 2015) was founded in 1948.

  • Where is Allergan (Acquired 2015) headquartered?

    Allergan (Acquired 2015) is headquartered in Irvine, CA.

  • What is the size of Allergan (Acquired 2015)?

    Allergan (Acquired 2015) has 16,000 total employees.

  • What industry is Allergan (Acquired 2015) in?

    Allergan (Acquired 2015)’s primary industry is Pharmaceuticals.

  • Is Allergan (Acquired 2015) a private or public company?

    Allergan (Acquired 2015) is a Private company.

  • What is the current valuation of Allergan (Acquired 2015)?

    The current valuation of Allergan (Acquired 2015) is .

  • What is Allergan (Acquired 2015)’s current revenue?

    The current revenue for Allergan (Acquired 2015) is .

  • Who are Allergan (Acquired 2015)’s investors?

    Bausch Health Companies, Compass Technology Partners, Pentwater Capital Management, Pershing Square Holdings, and T. Rowe Price Group have invested in Allergan (Acquired 2015).

  • When was Allergan (Acquired 2015) acquired?

    Allergan (Acquired 2015) was acquired on 17-Mar-2015.

  • Who acquired Allergan (Acquired 2015)?

    Allergan (Acquired 2015) was acquired by Allergan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »